Importantly, the programmed cell death protein 1/programmed cell death-ligand 1 (PD-1/PD-L1) pathway is one of the most studied immune checkpoint pathways to inactivate immune responses in the tumor microenvironment [16]. Here, PDCD1 is linked to neoplasm.